ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1063

Gender, Racial, and Geographic Trends in Mortality from Interstitial Lung Diseases Among Patients With Rheumatoid Arthritis in the U.S. Population, 1999–2020

Farheen Malik1, Jawad Ahmed2, Mandar Shah1, Ritika Uttam3 and Muhammad Fahimuddin1, 1Jacobi Medical Center, Bronx, NY, NY, 2Northwest Health Porter, Valpraiso, IN, 3Jacobi Medical Center, Bronx, NY

Meeting: ACR Convergence 2025

Keywords: gender, interstitial lung disease, Mortality, race/ethnicity, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1055–1087) Healthcare Disparities in Rheumatology Posters

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a common autoimmune disease affecting up to 1.0% of the US population. RA is most commonly associated with synovial inflammation and articular symptoms but is also associated with extra-articular manifestations. Interstitial lung disease (ILD) is one of the most important and common pulmonary manifestations of RA and it is associated with significant morbidity and mortality. We aim to find variations in the mortality trend of ILD in RA patients.

Methods: Death certificates from the CDC Wonder Database were analyzed from 1999 to 2020 for ILD (J84.1) and RA (M05 and M06) patients. Age-adjusted mortality rates (AAMR) per 100,000 individuals, average annual percentage change (AAPC), and annual percent change (APC) with respective 95% CI were calculated and stratified for gender, racial, age, and geographic factors.

Results: A total of 10171 ILD and RA-associated deaths occurred between 1999 and 2020 with an overall AAMR of 0.2. AAMR declined from 0.2 in 1999 to 0.1 in 2020 with an AAPC of -3.08 ( -4.79 to – 2.28; p< 0.01). From 1999 to 2014, a slight non-significant decrease was noted in mortality (APC -0.17), followed by a significant sharp decline from 2014 to 2017 (APC -24.09; p< 0.05)) and a gradual non-significant increase till 2020 (APC 6.70). Adults >55 years had higher AAMR than the population < 55 years of age, and AAMR continued to increase as age increased. Females accounted for 63.5% (n=6463) of deaths and had higher AAMR of 0.2 compared to men (0.1) but had a sharp decline noted in AAMR from 2017 to 2020 (APC -24.97 [-43.01 to -2.83]). In the racial and ethnic groups, non-Hispanic (NH) Black or African American and Asian or Pacific Islanders had the lowest AAMR of 0.1 whereas the highest was observed in American Indian or Alaska Natives (0.5). White population accounted for most deaths reported (80.7%) and a significant downtrend was noted in the mortality trend from 2014 to 2020 (APC -11.99; p< 0.01). There was no difference in AAMR between Rural (0.2) and Urban (0.2) settings, but later had a falling mortality trend from 2013 to 2016 (APC -23.64 [ -30.21 to -14.88], p< 0.01). The Northeast had the lowest AAMR of 0.1 whereas Midwest, South, and West had equally high AAMR of 0.2. Seven states (Idaho, Minnesota, Montana, New Mexico, Oregon, South Dakota, and Vermont) had the highest AAMR.

Conclusion: There has been a slight decrease in mortality rates from ILD in RA patients which could be due to advancements in treatment regimens. Females are more prone to developing autoimmune diseases, have higher AAMR, and therefore can contribute to a higher mortality burden. The older population was noted to have higher mortality rates. Noticeable differences were noted among different ethnic and racial groups as well as census regions and states in terms of mortality. Further research is warranted to identify the disparities noted.

Supporting image 1Mortality Trends of Interstitial Lung Disease in Rheumatoid Arthritis Patients in the U.S. Population, 1999–2020.

(A) By U.S. state; (B) By race/ethnicity; (C) By gender; (D) By rural vs. urban setting.


Disclosures: F. Malik: None; J. Ahmed: None; M. Shah: None; R. Uttam: None; M. Fahimuddin: None.

To cite this abstract in AMA style:

Malik F, Ahmed J, Shah M, Uttam R, Fahimuddin M. Gender, Racial, and Geographic Trends in Mortality from Interstitial Lung Diseases Among Patients With Rheumatoid Arthritis in the U.S. Population, 1999–2020 [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/gender-racial-and-geographic-trends-in-mortality-from-interstitial-lung-diseases-among-patients-with-rheumatoid-arthritis-in-the-u-s-population-1999-2020/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-racial-and-geographic-trends-in-mortality-from-interstitial-lung-diseases-among-patients-with-rheumatoid-arthritis-in-the-u-s-population-1999-2020/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology